Laura D Zambrano, Margaret M Newhams, Regina M Simeone, Katherine E Fleming-Dutra, Natasha Halasa, Michael Wu, Amber O Orzel-Lockwood, Satoshi Kamidani, Pia S Pannaraj, Kathleen Chiotos, Melissa A Cameron, Aline B Maddux, Jennifer E Schuster, Hillary Crandall, Michele Kong, Ryan A Nofziger, Mary A Staat, Samina S Bhumbra, Katherine Irby, Julie A Boom, Leila C Sahni, Janet R Hume, Shira J Gertz, Mia Maamari, Cindy Bowens, Emily R Levy, Tamara T Bradford, Tracie C Walker, Stephanie P Schwartz, Elizabeth H Mack, Judith A Guzman-Cottrill, Charlotte V Hobbs, Matt S Zinter, Natalie Z Cvijanovich, Katherine E Bline, Saul R Hymes, Angela P Campbell, Adrienne G Randolph
BACKGROUND AND OBJECTIVES: In June 2022, the mRNA COVID-19 vaccination was recommended for young children. We examined clinical characteristics and factors associated with vaccination status among vaccine-eligible young children hospitalized for acute COVID-19. METHODS: We enrolled inpatients aged 8 months to <5 years with acute community-acquired COVID-19 across 28 US pediatric hospitals from September 20, 2022 to May 31, 2023. We assessed demographic and clinical factors, including the highest level of respiratory support, and vaccination status defined as unvaccinated, incomplete, or complete primary series [at least 2 (Moderna) or 3 (Pfizer-BioNTech) mRNA vaccine doses ≥14 days before hospitalization]...
December 25, 2023: Pediatric Infectious Disease Journal